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How and How Longto Store Urine SamplesbeforeAlbuminRadioimmunoassay:
A Practical Response
Ottavio Giampietro, Giuseppe Penno, Aido Clerico,’ Lorella Cruschelli, and Mauro Cecere
We used three study protocols to check the dependence
of albumin stability, measured by an AlA, on different
temperatures, durations, and materials (i.e., assay tubes)
of urine storage. Albumin values obtained for samples
stored in three types of assay tubes (glass, polystyrene,
and polypropylene) throughout the 2 months of the first
(prospective) protocol were superimposable. The 24-h
storage of six urine samples at room temperature or at
4#{176}C,as well as 72-h storage at 4#{176}C,did not affect the
albumin measurement by AlA. After 2 months of storage
of these same six urine samples at -20 #{176}C,there was still
no albumin decrease. A significant albumin decrease
occurred (a mean of -5% per year, throughoutthe range
of albumin concentrationstested) when samples stored at
-20 #{176}Cwere reassayed by AlA after 2 years (second
protocol, retrospective). Finally, 3 of 21 (14.3%) urine
pools stored at -20 #{176}Cfor various periods (4-21 months)
showed a significant albumin loss after storage; the time
of storage as well the decrement rates of these 3 pools
differed from each other (third protocol, retrospective).
Short- and medium-term (2-6 months) freezing of urine
samples at -20 #{176}Cdoes not significantlyaffect the stabil-
ity of immunoreactive albumin. For longer preservation
periods, storage of urine samples at -70 #{176}Cmay be
preferable.
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Measurement of urinary albumin excretion in the
range of 20-200 mg/day, so-called microalbuminuria, is
used to evaluate kidney involvement in people with
diabetes mellitus (1, 2). Indeed, diabetic renal disease
may be reversible by tight metabolic control, if detected
early (1). Accordingly, screening to determine urinary
albumin excretion has become a frequent part of diabe-
tes care (1, 2).
Contradictory evidence (2-9) has been reported about
the effect of specimen storage conditions on the results
of these assays. Albumin in urine has been stated to be
stable at room temperature for several hours and for a
few weeks at 4#{176}Cwithout added preservative, which
implies that urine samples can be stored for a relatively
short time (from hours to some days) at 4#{176}Cuntil assay
(2). However, epidemiological and (or) multicenter stud-
ies require that several samples be collected, stored for
long periods (from several months to some years), and
eventually shipped to the laboratory before the assay.
Hence, storage conditions such as room temperature or
4#{176}Care not suitable; instead, freezing the urine sam-
ples seems more appropriate. Some authors claim that
storage of samples at -20 #{176}Cfor determination of uri-
nary albumin excretion by laser immunonephelometry
(5) or RIA (7) yields falsely low results, so that freezing
urine samples is not suitable. Others (3,8), like us (4,6,
9), are of the opinion that freezing urine samples at
-20#{176}C(or -70 #{176}C)does not in itself affect the albumin
assay, and thus recommend storing specimens at -20 #{176}C
(or -70 #{176}C)if the assay cannot be performed within a
few days (2-3 days at most).
To determine the best way to stabilize the albumin in
urine until assay, we stored under different conditions
and for different periods a large number of urine sam-
plea and pools treated in various ways.
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AlA of Urinary Albumin
We measured urinary albumin with a commercial
RIA (Albumin RIA 100; Pharmacia AB, Uppsala, Swe-
den) in which purified human serum albumin (HSA) is
the standard, 1I-labeled HSA is the tracer, and the
antiserum is specific for HSA. The bound and the free
phases were separated by a solid-phase system (anti-
rabbit IgG, raised in sheep, bound to Sepharose), and
the standard curve was prepared with solutions contain-
ing known amounts of purified HSA. The analytical
characteristics of this RIA have been reported in detail
(10). The assay was not significantly subject to interfer-
ence from bovine serum albumin, transferrin, or human
immunoglobulins.
The RIA was performed according to the manufactur-
er’s instructions. In brief, we added to all tubes 50 L of
the standard solutions or urine samples, 50 pL of the
tracer solution (-30 000-40 000 counts/mm of 1I-la-
beled HSA), and 2.0 mL of anti-HSA antiserum reagent;
mixed; and then incubated the samples for 1 h at room
temperature (18-22 #{176}C).After centrifugation (1500 x g
for 10 mm, 4#{176}C),the supernates were aspirated and
discarded, and the radioactivity of the precipitates was
counted in a well-type gamma counter.
The mean limit of detection of this RIA was 0.29 (SD
0.12) mg/L (n = 40). The mean (n = 40) within-assay
imprecision profile and the mean RIA standard curve are
shown in Figure 1. The working range [the concentration
range of albumin that was measured with an imprecision
(CV) <10%] was 2-62 mg/L; consequently, the urine
samples with albumin concentrations 60 mg/L were
reassayed after dilution. The between-assay variability
(CV) for a wide range of albumin concentrations (3.4-
60.1 mg/L) observed in 21 urine pools stored at -20 #{176}C
ranged between 5.6% and 27.2% (Figure 2), with a
pattern similar to the within-assay imprecision profile.
All sample values were measured and the index of
sensitivity, the precision profile, and quality control for
the RIA were performed according to a previously de-
scribed computer program (11, 12). The interpolation of
the dose-response curve was calculated by a four-pa-
rameter logistic function (12).
Urine Samples
Urine samples were collected from healthy subjects
and from normo-, micro-, and macroalbuminuric dia-
betic patieits. First-morning, 24-h, and overnight col-
lections were included in the study. Urinalysis and
urine cultures were performed on each specimen. No
preservative had been added to the urine collections,
and the samples were gently mixed, but not centrifuged,
before assay.
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Fig. 1. Mean imprecision profile (within-assay), working range (range
of albuminconcentration measured with an imprecIsion <10%), and
mean standard curve (insert) for AlA used to measure urinary
albuminin this study
ing various albumin concentrations (from 7.2 to 371.0
mg/L) were collected in sterile 100-mL urine culture
tubes and stored for different times (from 1 day to 2
months) at various temperatures [room temperature
(18-20#{176}C),4#{176}C,and -20 #{176}C]in several 2-mL aliquots
dispensed into three different types of assay tubes (glass,
polystyrene, and polypropylene) until assay. These spec-
imens were analyzed for albumin by the RIA in eight
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We used more than one protocol to check the depen-
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separate runs as follows: within 1 h from collection at
room temperature, withdrawing urine (50 L) for the
assay directly from the urine culture tubes (control
sample) and from each type of assay tube; after 24 h
(stored at room temperature and 4#{176}C);after 72 h (stored
at 4 and -20 #{176}C);and after 7, 14, 21, 28, and 60 days
(stored at -20 #{176}C).
Second experimental series. We assayed in five sepa-
rate runs two series of urine samples that had been
stored at -20 #{176}C:the first included 61 specimens that
had been assayed 2 years before by the same RIA
(albumin concentrations 2.0-344 mgfL, mean ± SD =
30.6 ± 50.7 mgIL); the second included 137 samples
assayed 4-.-5years before (albumin concentrations 0.3-
364 mgIL, mean ± SD = 13.1 ± 33.0 mgfL). Most of
these urine samples had been frozen and thawed more
than once before the last assay.
Third experimental series. We repeatedly assayed
(from 16 to 82 times in different experimental sessions;
total number of assays:692) over various periods (rang-
ing between 4 and 21 months) 21 urine pools stored at
-20 #{176}Cin 2-mL aliquots until assay.
Statistical Analysis
The statistical analysis was carried out by Macintosh
SE and Macintosh ilsi personal computers, with use of
the Stat View SE+#{176}””’#{176}program (1988 Abacus Con-
cepts, Inc.). The results are expressed as mean ± SD.
Results
First protocol. No difference [by repeated-measure
analysis of variance (ANOVA), P = 0.8472] was ob-
served among results obtained with the three types of
assay tubes throughout the 2 months of the experiment
(Figure 3).
The 24-h storage of six urinary samples at room
temperature (for polystyrene tubes, 89.8 ± 121.4 mg/L)
and at 4#{176}C(95.9 ± 140.8 mg/L), as well their 72-h
storage at 4#{176}C(114.1 ± 177.4 mg/L) did not affect the
measurement of albumin by RIA (P = 0.4532 by
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ANOVA), in comparison with the results determined
within 1 h after collection (113.1 ± 157.5 mg/L). Storage
of these same six urine samples at -20 #{176}Cfor 2 months
before assay produced no significant albumin loss (by
ANOVA, P = 0.8078) from the initial value (Figure 3).
Samples stored at -20 #{176}Cfor 2 years. We found a
significant decrease in albumin when urine samples
stored at -20 #{176}Cwere reassayed by RIA after 2 years.
The 61 urine samples frozen for 2 years had a mean
decrease in albumin of 13.2%: basal value, 30.6 ± 50.7
mg/L; values after 2 years, 26.5 ± 41.2 mg/L (P = 0.0153
by paired t-test). The 137 specimens stored at -20 #{176}Cfor
4-5 years had a mean albumin decrease of 21.8%: basal
value, 13.1 ± 33.0 mg/L; value after 4-5 years, 10.2 ±
23.6 mg/L (P = 0.0046 by paired t-test). These findings
indicate a mean loss of -5% per year throughout the
range of albumin concentrations in urine samples frozen
at -20 #{176}C,based on the assumption that the decrease is
a linear function of the storage time.
Urine pools. Only 3 of 21 (14.3%) pools stored at
-20 #{176}Cshowed a statistically significant albumin de-
crease during storage. The time of storage and the
decrement rates of these three pools all differed from
each other (Figure 4).
DiscussIon
Here we demonstrate that the material of the storage
and assay tubes-glass, polystyrene, or polypropylene-
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had no effect on urinary albumin measurement by RIA.
Moreover, in our hands, albumin in urine was suffi-
ciently stable at room temperature for 24 h and at
4-8 #{176}Cfor at least 3 days without added preservative,
thus confirming previous reports (2).
Because storing urine samples at 4#{176}Cfor longer than
3 days is impractical, the alternative is to freeze them.
To check whether storage at -20 #{176}Caffected albumin
assayed by RIA, we analyzed results from a prospective
protocol of urine storage and from two retrospective
series of urine samples frozen for different long periods
at -20 #{176}C.To minimize the effects of analytical variabil-
ity and bias (especially those due to the use of different
reagent lots) during the course of the study, we assayed
frozen specimens in different runs by RIA. Moreover, we
assayed both individual urine samples and pools in
different protocols, because some authors (13, 14) have
criticized the use of only pools in studies on the effectsof
time and temperature on albumin stability in urine.
The prospective protocol demonstrated that 2 months
of storage at -20#{176}Cdid not impair the accuracy of RIA
determinations of albumin in urine. These results, in
conjunction with those previously provided by our group
on the effects of specimen storage at -20 #{176}Cfor 6-7
months (6,9), strikingly indicate that albumin in urine
samples is not affected by freezing at -20 #{176}C,at least
not for short- or medium-term storage (6, 9). What
happens shortly after that is not known (no data are
available). However, after 2 (and still more, after 5)
years of storage at -20 #{176}C,a significant albumin loss-
albeit of negligible clinical relevance-does occur (sec.
ond protocol of this study). In fact, albumin from speci-
mens frozen long-term at -20 #{176}Cdecreased by -5% per
year throughout the entire range of albumin concentra-
tions. This loss is smaller than that previously reported
in other, shorter studies (5, 7, 8, 15). This decrement
rate of -5% per year would probably not be detectable
in experiments lasting <1 year, because this amount of
variation is usually less than the between-assay preci-
sion of the procedures routinely used to measure uri-
nary albumin (16) (Figures 1 and 2). This indirectly
confirms findings previously reported by us (6,9) and by
other laboratories (3, 17).
Because storage at -70 #{176}Chas been reported to be
adequate to prevent substantial degradation of immuno-
reactive albumin in urine samples for at least 160 days,
MacNeil et al. (8) recently proposed this alternative.
The third protocol of this study indicates that occa-
sionally, in individual instances, a more rapid decre-
ment rate of urinary albumin may occur (Figure 4),
suggesting that an unpredictable rate of degradation of
urinary albumin may be found among somesubjects(8).
At present, the reason for this is unknown, so that
anticipating the behavior of the single urine albumin
result in samples stored at -20 #{176}Cis not possible.
In conclusion, becauseour findings confirm that freez-
ing urine samples does not itself significantly affect the
stability of immunoreactive albumin, the question of
how to treat urine samples before assay needs to be
answered. If albumin cannot be measured within 1 day’s
storage at room temperature or within 2-3 days of
storage at 4#{176}C,freezing urine samples at -20 #{176}Cfor 4-6
months is advisable and should result in no clinically
significant albumin loss, regardless of the composition
of the storage tubes. For longer storage, we recommend
freezing the urine samples at -70 #{176}C.
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